Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by the incapability of pancreas to increase insulin secretion to compensate for insulin resistance in the peripheral tissues. T2DM is a multifactorial disease including several environmental factors with the presence of genetic predisposition. The transcription factor 7-like-2 gene (TCF7L2) rs7903146 (C/T) polymorphism is one of the most susceptible genes to T2DM discovered to date, with contribution to the disease through the Wnt/β-catenin signaling pathway affecting pancreatic islet development, expression of several genes involved in insulin granules exocytosis, and the incretin glucagon-like peptide 1 (GLP-1) gene. Then, TCF7L2 gene seems to affect diabetes susceptibility through B-cell dysfunction that is why we studied its association with T2DM in particular.
(2022). Transcription Factor 7-Like-2 (TCF7L2) rs7903146 (C/T) Polymorphism in Patients with Type 2 Diabetes Mellitus. Egyptian Society of Diabetes and Lipidology Journal, 2(1), -. doi: 10.21608/esdlj.2022.455728
MLA
. "Transcription Factor 7-Like-2 (TCF7L2) rs7903146 (C/T) Polymorphism in Patients with Type 2 Diabetes Mellitus", Egyptian Society of Diabetes and Lipidology Journal, 2, 1, 2022, -. doi: 10.21608/esdlj.2022.455728
HARVARD
(2022). 'Transcription Factor 7-Like-2 (TCF7L2) rs7903146 (C/T) Polymorphism in Patients with Type 2 Diabetes Mellitus', Egyptian Society of Diabetes and Lipidology Journal, 2(1), pp. -. doi: 10.21608/esdlj.2022.455728
VANCOUVER
Transcription Factor 7-Like-2 (TCF7L2) rs7903146 (C/T) Polymorphism in Patients with Type 2 Diabetes Mellitus. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(1): -. doi: 10.21608/esdlj.2022.455728
)
